One of the issues frequently popping up in debates about synthetic biology (synbio) is the possibility of introducing new and yet unknown types of biological risks.
Notions of ‘Responsible Research and Innovation’ (RRI) or ‘Responsible Innovation’ have evolved over at least ten years, both in the EU and the US.
What is the future of biotechnology? How can we create an ecosystem that integrates traditional and non-traditional actors and bolsters innovation?
On 14-15 January 2016, the European Economic and Social Committee (EESC) hosted the joint final event of 4 European projects, all working with the concept of RRI.
Synthetic biology is already being used in the processing of biomass to produce industrial goods such as biofuels, commodities for the chemical industry and ingredients for consumer goods.
What are the potential benefits and risks associated with altering human DNA? Is science and society prepared for the ethical, moral, and policy questions raised by new technological capabilities?
I don't know if you have come across this: a completly RRI by-product of the project WormBoys developed by Valencia Biocampus Team for iGEM 2013. Ten stories about Syn-Bio, in a positive and negative version!!